Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
Pancreatic Ductal Adenocarcinoma (PDAC) constitutes a leading cause of cancer death globally. Its mortality remains unaltered despite the considerable scientific progress made in the fields of diagnostics and treatment. Exosomes comprise of small extracellular vesicles secreted by nearly all cells;...
Main Authors: | Stavros P. Papadakos, Nikolaos Dedes, Alexandros Pergaris, Maria Gazouli, Stamatios Theocharis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/7/3620 |
Similar Items
-
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
by: Stavros P. Papadakos, et al.
Published: (2023-02-01) -
Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
by: Natalia Georgantzoglou, et al.
Published: (2021-03-01) -
The EPH/Ephrin System in Colorectal Cancer
by: Stavros P. Papadakos, et al.
Published: (2022-03-01) -
Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes
by: Dimitrios Goutas, et al.
Published: (2022-03-01) -
Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment
by: Xingliang Fang, et al.
Published: (2023-05-01)